Literature DB >> 21057801

Baroreflex activation as a novel therapeutic strategy for diastolic heart failure.

Mathias C Brandt, Navid Madershahian, Ralf Velden, Uta C Hoppe.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21057801     DOI： 10.1007/s00392-010-0249-0

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  9 in total

1.  Left ventricular hypertrophy and the 'cardiogenic reflex' in man.

Authors:  C Giannattasio; B M Cattaneo; G Seravalle; G Grassi; G Mancia
Journal:  J Hypertens Suppl       Date:  1991-12

Review 2.  2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

3.  Mechanism of prolongation of the R-R interval with electrical stimulation of the carotid sinus nerves in man.

Authors:  D L Eckberg; G F Fletcher; E Braunwald
Journal:  Circ Res       Date:  1972-01       Impact factor: 17.367

4.  The perindopril in elderly people with chronic heart failure (PEP-CHF) study.

Authors:  John G F Cleland; Michal Tendera; Jerzy Adamus; Nick Freemantle; Lech Polonski; Jacqueline Taylor
Journal:  Eur Heart J       Date:  2006-09-08       Impact factor: 29.983

Review 5.  Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy.

Authors:  Paolo Palatini; Athanase Benetos; Stevo Julius
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Authors:  Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

7.  Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure.

Authors:  D M Kaye; G W Lambert; J Lefkovits; M Morris; G Jennings; M D Esler
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

8.  Irbesartan in patients with heart failure and preserved ejection fraction.

Authors:  Barry M Massie; Peter E Carson; John J McMurray; Michel Komajda; Robert McKelvie; Michael R Zile; Susan Anderson; Mark Donovan; Erik Iverson; Christoph Staiger; Agata Ptaszynska
Journal:  N Engl J Med       Date:  2008-11-11       Impact factor: 91.245

9.  Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension.

Authors:  Joanna Burns; Mohan U Sivananthan; Stephen G Ball; Alan F Mackintosh; David A S G Mary; John P Greenwood
Journal:  Circulation       Date:  2007-03-26       Impact factor: 29.690
  9 in total
  6 in total

Review 1.  Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure.

Authors:  Gino Seravalle; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-03-27

Review 2.  The baroreceptor as a therapeutic target for heart failure.

Authors:  Edoardo Gronda; Eric G Lovett; Michela Tarascio; Dimitrios Georgakopoulos; Guido Grassi; Emilio Vanoli
Journal:  J Cardiovasc Transl Res       Date:  2014-02-22       Impact factor: 4.132

Review 3.  An updated review of cardiac devices in heart failure.

Authors:  C Murphy; H Zafar; F Sharif
Journal:  Ir J Med Sci       Date:  2017-03-25       Impact factor: 1.568

4.  [Diastolic heart failure: heart failure with preserved ejection fraction].

Authors:  P Dovjak
Journal:  Z Gerontol Geriatr       Date:  2013-01       Impact factor: 1.281

5.  Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.

Authors:  Edoardo Gronda; Gino Seravalle; Gianmaria Brambilla; Giuseppe Costantino; Andrea Casini; Ali Alsheraei; Eric G Lovett; Giuseppe Mancia; Guido Grassi
Journal:  Eur J Heart Fail       Date:  2014-07-28       Impact factor: 15.534

6.  Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States.

Authors:  John Bisognano; John E Schneider; Shawn Davies; Robert L Ohsfeldt; Elizabeth Galle; Ivana Stojanovic; Thomas F Deering; JoAnn Lindenfeld; Michael R Zile
Journal:  BMC Cardiovasc Disord       Date:  2021-03-26       Impact factor: 2.298
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.